Free Trial

Schmitt Industries (SMIT) Competitors

Schmitt Industries logo
$0.02 0.00 (0.00%)
As of 05/22/2026

SMIT vs. SPEC, TBIO, THMO, HTGMQ, and OLITW

Should you buy Schmitt Industries stock or one of its competitors? MarketBeat compares Schmitt Industries with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Schmitt Industries include Spectaire (SPEC), Telesis Bio (TBIO), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), and OmniLit Acquisition (OLITW). These companies are all part of the "measuring and control equipment" industry.

How does Schmitt Industries compare to Spectaire?

Spectaire (NASDAQ:SPEC) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

26.5% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Schmitt Industries' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
Schmitt Industries N/A N/A N/A

Spectaire has a beta of -6.91, meaning that its stock price is 791% less volatile than the broader market. Comparatively, Schmitt Industries has a beta of 0.11, meaning that its stock price is 89% less volatile than the broader market.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
Schmitt Industries Neutral

Spectaire has higher earnings, but lower revenue than Schmitt Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

Summary

Spectaire beats Schmitt Industries on 4 of the 7 factors compared between the two stocks.

How does Schmitt Industries compare to Telesis Bio?

Schmitt Industries (NASDAQ:SMIT) and Telesis Bio (NASDAQ:TBIO) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
Telesis Bio -336.59%N/A -61.89%

Schmitt Industries has higher earnings, but lower revenue than Telesis Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
Telesis Bio Neutral

37.6% of Telesis Bio shares are owned by institutional investors. 17.1% of Schmitt Industries shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Schmitt Industries has a beta of 0.11, meaning that its share price is 89% less volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.29, meaning that its share price is 129% more volatile than the broader market.

Summary

Schmitt Industries and Telesis Bio tied by winning 4 of the 8 factors compared between the two stocks.

How does Schmitt Industries compare to ThermoGenesis?

ThermoGenesis (NASDAQ:THMO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

Schmitt Industries has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Schmitt Industries N/A N/A N/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Schmitt Industries Neutral

ThermoGenesis has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Schmitt Industries has a beta of 0.11, suggesting that its share price is 89% less volatile than the broader market.

Summary

ThermoGenesis beats Schmitt Industries on 3 of the 5 factors compared between the two stocks.

How does Schmitt Industries compare to HTG Molecular Diagnostics?

Schmitt Industries (NASDAQ:SMIT) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Schmitt Industries has a beta of 0.11, meaning that its share price is 89% less volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.25, meaning that its share price is 225% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Schmitt Industries has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
HTG Molecular Diagnostics Neutral

Summary

Schmitt Industries beats HTG Molecular Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Schmitt Industries compare to OmniLit Acquisition?

Schmitt Industries (NASDAQ:SMIT) and OmniLit Acquisition (NASDAQ:OLITW) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
OmniLit Acquisition N/A N/A N/A

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
OmniLit Acquisition Neutral

OmniLit Acquisition has lower revenue, but higher earnings than Schmitt Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

Summary

Schmitt Industries beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks.

Get Schmitt Industries News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMIT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMIT vs. The Competition

MetricSchmitt IndustriesProcess control instruments IndustryIndustrials SectorNASDAQ Exchange
Market Cap$57K$57K$9.55B$12.49B
Dividend YieldN/AN/A3.55%5.28%
P/E RatioN/AN/A25.7025.81
Price / Sales0.010.015,275.5387.99
Price / CashN/AN/A27.5956.67
Price / BookN/AN/A5.097.22
Net Income-$3.28M-$3.28M$792.97M$335.78M
7 Day PerformanceN/AN/A2.53%4.46%
1 Month PerformanceN/AN/A2.86%3.07%
1 Year PerformanceN/AN/A33.45%37.79%

Schmitt Industries Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMIT
Schmitt Industries
N/A$0.02
flat
N/AN/A$57K$9.89MN/A160
SPEC
Spectaire
N/AN/AN/AN/A$9KN/AN/A8
TBIO
Telesis Bio
N/A$0.00
flat
N/AN/A$2K$225.09MN/A200
THMO
ThermoGenesis
N/A$0.00
flat
N/AN/A$1K$9.61MN/A40
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90

Related Companies and Tools


This page (NASDAQ:SMIT) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners